Unimpaired beta adrenergic responses during prazosin administration.
We have examined insulin-induced hypoglycemia to determine whether prazosin inhibits the response to sympathetic stimulation, either centrally or at beta adrenergic receptors. Nine patients with essential hypertension were studied during administration of prazosin, hydralazine or placebo. Plasma renin activity increased significantly with hydralazine and was unchanged during prazosin administration. In response to insulin, blood glucose decreased equally with both drugs and placebo, and small increases in dopamine beta-hydroxylase occurred. Plasma renin activity and heart rate increased during hypoglycemia; the increases were greater in patients taking prazosin or hydralazine. The unimpaired responses of plasma dopamine beta-hydroxylase, renin activity and heart rate to insulin-induced hypoglycemia provide evidence that prazosin does not block either the sympathetic discharge elicited by central stimulation (hypoglycemia) or the responses mediated through beta adrenergic receptors.
D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D004299:Dopamine beta-Hydroxylase / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006830:Hydralazine; D006973:Hypertension / Q000503:physiopathology*; D007328:Insulin; D011224:Prazosin; D011799:Quinazolines; D011941:Receptors, Adrenergic / Q000502:physiology*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects / Q000502:physiology*; D012083:Renin / Q000097:blood
D001786:Blood Glucose; D007328:Insulin; D011799:Quinazolines; D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D006830:Hydralazine; D004299:Dopamine beta-Hydroxylase; D012083:Renin; D011224:Prazosin